During the past decade, Skane University Hospital conducted 213 clinical trials. In the 10-year time frame, 213 clinical trials started and 44 clinical trials were completed, i.e. on average, 20.7% percent of trials that started reached the finish line to date. In the past 5 years, 91 clinical trials started and 26 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Skane University Hospital" #1 sponsor was "Region Skane" with 60 trials, followed by "Lund University Hospital" with 12 trials sponsored, "Skane University Hospital" with 11 trials sponsored, "Lund University" with 10 trials sponsored and "Uppsala University" with 10 trials sponsored. Other sponsors include 219 different institutions and companies that sponsored additional 156 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Skane University Hospital" #1 collaborator was "Skane University Hospital" with 29 trials as a collaborator, "Lund University" with 26 trials as a collaborator, "Sahlgrenska University Hospital, Sweden" with 19 trials as a collaborator, "Karolinska University Hospital" with 16 trials as a collaborator and "University Hospital, Linkoeping" with 14 trials as a collaborator. Other collaborators include 425 different institutions and companies that were collaborators in the rest 306 trials.

According to Clinical.Site data, the most researched conditions in "Skane University Hospital" are "Multiple Myeloma" (9 trials), "Cardiovascular Diseases" (7 trials), "Coronary Artery Disease" (7 trials), "Heart Failure" (6 trials) and "Stroke" (6 trials). Many other conditions were trialed in "Skane University Hospital" in a lesser frequency.

Most popular intervention types in "Skane University Hospital" are "Drug" (143 trials), "Device" (61 trials), "Other" (54 trials), "Procedure" (41 trials) and "Biological" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (33 trials), "Dexamethasone" (5 trials), "Atezolizumab" (4 trials), "Bortezomib" (4 trials) and "Ibrutinib" (4 trials). Other intervention names were less common.

The vast majority of trials in "Skane University Hospital" are 292 trials for "All" genders, 21 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are 127 active trials in "Skane University Hospital". 4 are not yet recruiting, 86 are recruiting, 32 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 156 completed trials in Skane University Hospital, 3 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Skane University Hospital, 17 "Phase 1" clinical trials were conducted, 67 "Phase 2" clinical trials and 70 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 20 trials, and there were also 107 trials that are defined as “Not Applicable".